The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

CUROSURF 240 mg/vial Endotracheopulmonary instillation, suspension

Chiesi Farmaceutici S.p.A.PA0584/005/002

Main Information

Trade NameCUROSURF 240 mg/vial Endotracheopulmonary instillation, suspension
Active SubstancesPorcine lung surfactant
Dosage FormEndotracheopulmonary instillation, suspension
Licence HolderChiesi Farmaceutici S.p.A.
Licence NumberPA0584/005/002

Group Information

ATC CodeR07AA Lung surfactants
R07AA02 natural phospholipids


License statusAuthorised
Licence Issued08/09/1994
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back